Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.62
+0.29 (5.44%)
At close: Mar 9, 2026, 4:00 PM EDT
5.61
-0.01 (-0.18%)
After-hours: Mar 9, 2026, 7:56 PM EDT
Immuneering Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2019 |
| Cash & Equivalents | 128.65 | 36.14 | 59.41 | 72.64 | 74.89 | Upgrade
|
| Short-Term Investments | 44.19 | - | 26.26 | 32.89 | 74.31 | Upgrade
|
| Cash & Short-Term Investments | 172.83 | 36.14 | 85.67 | 105.52 | 149.2 | Upgrade
|
| Cash Growth | 378.17% | -57.81% | -18.82% | -29.27% | 302.26% | Upgrade
|
| Receivables | - | - | - | 0.01 | 0.25 | Upgrade
|
| Prepaid Expenses | 3.41 | 3.44 | 3.42 | 3.21 | 2.89 | Upgrade
|
| Total Current Assets | 176.25 | 39.59 | 89.08 | 108.75 | 152.33 | Upgrade
|
| Property, Plant & Equipment | 4.26 | 4.79 | 5.4 | 5.78 | 6.13 | Upgrade
|
| Long-Term Investments | 44.18 | - | - | - | 1 | Upgrade
|
| Goodwill | 6.69 | 6.69 | 6.69 | 6.69 | 6.7 | Upgrade
|
| Other Intangible Assets | 0.32 | 0.35 | 0.38 | 0.41 | 0.44 | Upgrade
|
| Other Long-Term Assets | 0.28 | 1.3 | 1.03 | 0.74 | 0.1 | Upgrade
|
| Total Assets | 231.99 | 52.71 | 102.58 | 122.37 | 166.7 | Upgrade
|
| Accounts Payable | 1.54 | 1.96 | 2.11 | 3.15 | 1.39 | Upgrade
|
| Accrued Expenses | 7.84 | 4.97 | 5.17 | 4.5 | 3.97 | Upgrade
|
| Current Portion of Leases | 0.4 | 0.34 | 0.3 | 0.38 | 0.27 | Upgrade
|
| Other Current Liabilities | 0.29 | 0.23 | 0.26 | 0.02 | - | Upgrade
|
| Total Current Liabilities | 10.07 | 7.5 | 7.85 | 8.05 | 5.63 | Upgrade
|
| Long-Term Leases | 3.43 | 3.82 | 4.16 | 4.46 | 5.09 | Upgrade
|
| Total Liabilities | 13.5 | 11.33 | 12.01 | 12.52 | 10.72 | Upgrade
|
| Common Stock | 0.06 | 0.03 | 0.03 | 0.03 | 0.03 | Upgrade
|
| Additional Paid-In Capital | 498.66 | 265.65 | 253.81 | 219.64 | 215.28 | Upgrade
|
| Retained Earnings | -280.32 | -224.3 | -163.26 | -109.79 | -59.27 | Upgrade
|
| Comprehensive Income & Other | 0.08 | - | -0 | -0.03 | -0.05 | Upgrade
|
| Total Common Equity | 218.48 | 41.39 | 90.58 | 109.85 | 155.98 | Upgrade
|
| Shareholders' Equity | 218.48 | 41.39 | 90.58 | 109.85 | 155.98 | Upgrade
|
| Total Liabilities & Equity | 231.99 | 52.71 | 102.58 | 122.37 | 166.7 | Upgrade
|
| Total Debt | 3.82 | 4.16 | 4.46 | 4.84 | 5.36 | Upgrade
|
| Net Cash (Debt) | 169.01 | 31.98 | 81.2 | 100.68 | 144.83 | Upgrade
|
| Net Cash Growth | 428.45% | -60.61% | -19.35% | -30.48% | 297.13% | Upgrade
|
| Net Cash Per Share | 3.84 | 1.07 | 2.86 | 3.82 | 10.64 | Upgrade
|
| Filing Date Shares Outstanding | 64.65 | 35.89 | 29.28 | 26.44 | 26.38 | Upgrade
|
| Total Common Shares Outstanding | 64.65 | 31.05 | 29.27 | 26.42 | 26.32 | Upgrade
|
| Working Capital | 166.17 | 32.08 | 81.24 | 100.69 | 146.7 | Upgrade
|
| Book Value Per Share | 3.38 | 1.33 | 3.09 | 4.16 | 5.93 | Upgrade
|
| Tangible Book Value | 211.47 | 34.35 | 83.51 | 102.75 | 148.84 | Upgrade
|
| Tangible Book Value Per Share | 3.27 | 1.11 | 2.85 | 3.89 | 5.65 | Upgrade
|
| Machinery | - | 1.91 | 1.83 | 1.5 | 0.83 | Upgrade
|
| Leasehold Improvements | - | 0.3 | 0.3 | 0.29 | 0.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.